GILD vs LIVN · P/E 18, rev $7.80B vs P/E 41, rev $752.8M
Gilead Sciences Inc (GILD) versus LivaNova PLC (LIVN) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
LivaNova PLC (LIVN) is a medical devices company listed on NASDAQ.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported LIVN revenue for 2026-06-30 was $752.8M. Net income was $130.9M. LIVN currently screens at market cap $4.40B and trailing P/E 40.8.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. LIVN currently screens at market cap $4.40B and trailing P/E 40.8.
Not investment advice. Open the GILD and LIVN stock pages for the full models.
Not investment advice.